Cargando…
Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
There is growing evidence for the use of pharmacogenomics in psychotropic prescribing. People with intellectual disabilities are disproportionately prescribed psychotropics and are at risk of polypharmacy. There is an urgent need for safeguards to prevent psychotropic overprescribing but it is equal...
Autores principales: | Perera, Bhathika, Steward, Charles, Courtenay, Ken, Andrews, Timothy, Shankar, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438475/ https://www.ncbi.nlm.nih.gov/pubmed/35975635 http://dx.doi.org/10.1192/bjo.2022.554 |
Ejemplares similares
-
COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services
por: Naqvi, Danial, et al.
Publicado: (2021) -
UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
por: Deb, Shoumitro, et al.
Publicado: (2020) -
Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care
por: Shankar, Rohit, et al.
Publicado: (2018) -
Sleep: the neglected life factor in adults with intellectual disabilities
por: Korb, Laura, et al.
Publicado: (2023) -
Attention-deficit hyperactivity disorder in people with intellectual disability: statistical approach to developing a bespoke screening tool
por: Sawhney, Indermeet, et al.
Publicado: (2021)